Top

Published in:

Open Access 01-12-2010 | Research

Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock

Authors: H Bryant Nguyen, Manisha Loomba, James J Yang, Gordon Jacobsen, Kant Shah, Ronny M Otero, Arturo Suarez, Hemal Parekh, Anja Jaehne, Emanuel P Rivers

Published in: Journal of Inflammation | Issue 1/2010

Abstract

Background

Lactate clearance, a surrogate for the magnitude and duration of global tissue hypoxia, is used diagnostically, therapeutically and prognostically. This study examined the association of early lactate clearance with selected inflammatory, coagulation, apoptosis response biomarkers and organ dysfunction scores in severe sepsis and septic shock.

Methods

Measurements of serum arterial lactate, biomarkers (interleukin-1 receptor antagonist, interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-alpha, intercellular adhesion molecule-1, high mobility group box-1, D-Dimer and caspase-3), and organ dysfunction scores (Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology Score II, Multiple Organ Dysfunction Score, and Sequential Organ Failure Assessment) were obtained in conjunction with a prospective, randomized study examining early goal-directed therapy in severe sepsis and septic shock patients presenting to the emergency department (ED). Lactate clearance was defined as the percent change in lactate levels after six hours from a baseline measurement in the ED.

Results

Two-hundred and twenty patients, age 65.0 +/- 17.1 years, were examined, with an overall lactate clearance of 35.5 +/- 43.1% and in-hospital mortality rate of 35.0%. Patients were divided into four quartiles of lactate clearance, -24.3 +/- 42.3, 30.1 +/- 7.5, 53.4 +/- 6.6, and 75.1 +/- 7.1%, respectively (p < 0.01). The mean levels of all biomarkers and organ dysfunction scores over 72 hours were significantly lower with higher lactate clearance quartiles (p < 0.01). There was a significant decreased in-hospital, 28-day, and 60-day mortality in the higher lactate clearance quartiles (p < 0.01).

Conclusions

Early lactate clearance as a surrogate for the resolution of global tissue hypoxia is significantly associated with decreased levels of biomarkers, improvement in organ dysfunction and outcome in severe sepsis and septic shock.

Available only for authorised users

Karimova A, Pinsky DJ: The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med. 2001, 27: 19-31. 10.1007/s001340000790.PubMedCrossRef

Rivers EP, Kruse JA, Jacobsen G, Shah K, Loomba M, Otero R, Childs EW: The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med. 2007, 35: 2016-24. 10.1097/01.CCM.0000281637.08984.6E.PubMedCrossRef

Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 2001, 29: S99-106. 10.1097/00003246-200107001-00032.PubMedCrossRef

Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ, Faist E, Reinhart K: Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med. 2003, 31: 1560-7. 10.1097/01.CCM.0000065186.67848.3A.PubMedCrossRef

Nadiri A, Wolinski MK, Saleh M: The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. J Immunol. 2006, 177: 4239-45.PubMedCrossRef

Trzeciak S, Rivers EP: Emergency department overcrowding in the United States: an emerging threat to patient safety and public health. Emerg Med J. 2003, 20: 402-5. 10.1136/emj.20.5.402.PubMedPubMedCentralCrossRef

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-77. 10.1056/NEJMoa010307.PubMedCrossRef

Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, Kline JA: The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med. 2008, 36: 2734-9. 10.1097/CCM.0b013e318186f839.PubMedPubMedCentralCrossRef

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41.PubMedCrossRef

10.

Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA: Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004, 32: 1637-42. 10.1097/01.CCM.0000132904.35713.A7.PubMedCrossRef

11.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-74.

12.

Cohen J: The immunopathogenesis of sepsis. Nature. 2002, 420: 885-91. 10.1038/nature01326.PubMedCrossRef

13.

Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970, 41: 989-1001.PubMedCrossRef

14.

Kompanje EJ, Jansen TC, Hoven van der B, Bakker J: The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814-1869) in January 1843. Intensive. Care Med. 2007, 33: 1967-71. 10.1007/s00134-007-0788-7.CrossRef

15.

Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ: Serial lactate determinations during circulatory shock. Crit Care Med. 1983, 11: 449-51.PubMedCrossRef

16.

Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL: Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996, 171: 221-6. 10.1016/S0002-9610(97)89552-9.PubMedCrossRef

17.

James JH, Luchette FA, McCarter FD, Fischer JE: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999, 354: 505-8. 10.1016/S0140-6736(98)91132-1.PubMedCrossRef

18.

Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009, 37: 1670-7. 10.1097/CCM.0b013e31819fcf68.PubMedCrossRef

19.

Yang CS, Qiu HB, Huang YZ, Xie JF, Mo M, Liu SQ, Yang Y: Prospective research on the prognosis of septic shock based on the change of lactate concentration in arterial blood. Zhonghua Wai Ke Za Zhi. 2009, 47: 685-8.PubMed

20.

Seear MD, Scarfe JC, LeBlanc JG: Predicting major adverse events after cardiac surgery in children. Pediatr Crit Care Med. 2008, 9: 606-11. 10.1097/PCC.0b013e31818d1971.PubMedCrossRef

21.

Basaran M, Sever K, Kafali E, Ugurlucan M, Sayin OA, Tansel T, Alpagut U, Dayioglu E, Onursal E: Serum lactate level has prognostic significance after pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2006, 20: 43-7. 10.1053/j.jvca.2004.10.010.PubMedCrossRef

22.

Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, Brodaty D: Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 2003, 123: 1361-6. 10.1378/chest.123.5.1361.PubMedCrossRef

23.

Rady MY, Rivers EP, Martin GB, Smithline H, Appleton T, M NR: Continuous central venous oximetry and shock index in the emergency department: use in the evaluatio of clinical shock. American Journal of Emergency Medicine. 1992, 10: 538-41. 10.1016/0735-6757(92)90178-Z.PubMedCrossRef

24.

Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, Laggner AN: Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore). 2004, 83: 274-9. 10.1097/01.md.0000141098.46118.4c.CrossRef

25.

Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J: Lactate clearance and survival following injury. J Trauma. 1993, 35: 584-8. 10.1097/00005373-199310000-00014. discussion 588-9PubMedCrossRef

26.

McNelis J, Marini CP, Jurkiewicz A, Szomstein S, Simms HH, Ritter G, Nathan IM: Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 2001, 182: 481-5. 10.1016/S0002-9610(01)00755-3.PubMedCrossRef

27.

Watanabe I, Mayumi T, Arishima T, Takahashi H, Shikano T, Nakao A, Nagino M, Nimura Y, Takezawa J: Hyperlactemia can predict the prognosis of liver resection. Shock. 2007, 28: 35-8. 10.1097/shk.0b013e3180310ca9.PubMedCrossRef

28.

Antonelli M, Levy M, Andrews PJ, Chastre J, Hudson LD, Manthous C, Meduri GU, Moreno RP, Putensen C, Stewart T, Torres A: Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007, 33: 575-90. 10.1007/s00134-007-0531-4.PubMedCrossRef

29.

Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, Lustgarten J, Bassin AS, Davison L, Chernow B: The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994, 272: 1678-85. 10.1001/jama.272.21.1678.PubMedCrossRef

30.

Levy MM, Macias WL, Vincent JL, Russell JA, Silva E, Trzaskoma B, Williams MD: Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005, 33: 2194-2201. 10.1097/01.CCM.0000182798.39709.84.PubMedCrossRef

31.

De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med. 2006, 34: 1918-24. 10.1097/01.CCM.0000220498.48773.3C.PubMedCrossRef

32.

Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, Brett J, Wolitzky BA, Norton C, Plocinski J, Benjamin W: Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992, 90: 2333-9. 10.1172/JCI116122.PubMedPubMedCentralCrossRef

33.

Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D: Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem. 1995, 270: 11463-71. 10.1074/jbc.270.19.11463.PubMedCrossRef

34.

Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T, Kuwabara K: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 1994, 93: 1564-70. 10.1172/JCI117135.PubMedPubMedCentralCrossRef

35.

Leeper-Woodford SK, Fisher BJ, Sugerman HJ, Fowler AAd: Pharmacologic reduction in tumor necrosis factor activity of pulmonary alveolar macrophages. Am J Respir Cell Mol Biol. 1993, 8: 169-75.PubMedCrossRef

36.

Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991, 3: 189-94. 10.1016/1043-4666(91)90015-6.PubMedCrossRef

37.

Toda K, Kayano K, Karimova A, Naka Y, Fujita T, Minamoto K, Wang CY, Pinsky DJ: Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. Circ Res. 2000, 86: 166-74.PubMedCrossRef

38.

Wang CY, Naka Y, Liao H, Oz MC, Springer TA, Gutierrez-Ramos JC, Pinsky DJ: Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ Res. 1998, 82: 762-72.PubMedCrossRef

39.

Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ: Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest. 1995, 95: 2720-8. 10.1172/JCI117974.PubMedPubMedCentralCrossRef

40.

Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood. 1989, 74: 1704-10.PubMed

41.

Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun. 1992, 60: 2835-42.PubMedPubMedCentral

42.

Phua J, Koay ES, Lee KH: Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock. 2008, 29: 328-33. 10.1097/SHK.0b013e318150716b.PubMedCrossRef

43.

Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med. 2007, 33: 1347-53. 10.1007/s00134-007-0691-2.PubMedCrossRef

44.

Sama AE, D'Amore J, Ward MF, Chen G, Wang H: Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad Emerg Med. 2004, 11: 867-73.PubMed

45.

Levi M, ten Cate H, Poll van der T, van Deventer SJ: Pathogenesis of disseminated intravascular coagulation in sepsis. Jama. 1993, 270: 975-9. 10.1001/jama.270.8.975.PubMedCrossRef

46.

Kobayashi S, Gando S, Morimoto Y, Nanzaki S, Kemmotsu O: Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Surg Today. 2001, 31: 853-9. 10.1007/s005950170022.PubMedCrossRef

47.

Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest. 1993, 103: 1536-42. 10.1378/chest.103.5.1536.PubMedCrossRef

48.

Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS: D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 2002, 121: 1262-8. 10.1378/chest.121.4.1262.PubMedCrossRef

49.

Quick G, Eisenberg P: Bedside measurement of D-dimer in the identification of bacteremia in the emergency department. J Emerg Med. 2000, 19: 217-23. 10.1016/S0736-4679(00)00230-4.PubMedCrossRef

50.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.PubMedCrossRef

51.

Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE: Endothelial cell apoptosis in sepsis. Crit Care Med. 2002, 30: S225-8. 10.1097/00003246-200205001-00009.PubMedCrossRef

52.

Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL: Apoptosis in sepsis: a new target for therapeutic exploration. Faseb J. 2001, 15: 879-92. 10.1096/fj.00-058rev.PubMedCrossRef

53.

Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A, Hotchkiss RS: Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. Faseb J. 2007, 21: 708-19. 10.1096/fj.06-6805com.PubMedCrossRef

54.

Brunelle JK, Chandel NS: Oxygen deprivation induced cell death: an update. Apoptosis. 2002, 7: 475-82. 10.1023/A:1020668923852.PubMedCrossRef

55.

Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004, 32: 2173-82.PubMed

56.

Opal SM, Fisher CJ, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997, 25: 1115-24. 10.1097/00003246-199707000-00010.PubMedCrossRef

57.

Sevransky JE, Nour S, Susla GM, Needham DM, Hollenberg S, Pronovost P: Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Crit Care. 2007, 11: R67-10.1186/cc5948.PubMedPubMedCentralCrossRef

Title: Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock
Authors: H Bryant Nguyen
Manisha Loomba
James J Yang
Gordon Jacobsen
Kant Shah
Ronny M Otero
Arturo Suarez
Hemal Parekh
Anja Jaehne
Emanuel P Rivers
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Journal of Inflammation / Issue 1/2010
Electronic ISSN: 1476-9255
DOI: https://doi.org/10.1186/1476-9255-7-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Defining human mesenchymal stem cell efficacy in vivo

Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages

Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study

Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 protein

Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemorrhagic shock/resuscitation in a porcine model

Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials